nutch_noindex
CANCELAR
/nutch_noindex

Hayden Schwenk, MD

  • Hayden Tyler Schwenk

Especialidades

Infectious Disease

Trabajo y Educación

Formación Profesional

University of Texas Southwestern Medical Center, Dallas, TX, 2006

Residencia

Lucile Packard Children's Hospital, Palo Alto, CA, 2009

Compañerismo

Boston Children's Hospital, Boston, MA, 2013

Certificaciones Médicas

Pediatric Infectious Disease, American Board of Pediatrics

Pediatrics, American Board of Pediatrics

Todo Publicaciones

A quality improvement initiative to optimize dosing of surgical antimicrobial prophylaxis. Paediatric anaesthesia Caruso, T. J., Wang, E., Schwenk, H. T., Scheinker, D., Yeverino, C., Tweedy, M., Maheru, M., Sharek, P. J. 2017; 27 (7): 702-710

Abstract

The risk of surgical site infections is reduced with appropriate timing and dosing of preoperative antimicrobials. Based on evolving national guidelines, we increased the preoperative dose of cefazolin from 25 to 30 mgkg(-1) . This quality improvement project describes an improvement initiative to develop standard work processes to ensure appropriate dosing.The primary aim was to deliver cefazolin 30 mgkg(-1) to at least 90% of indicated patients. The secondary aim was to determine differences between accuracy of cefazolin doses when given as an electronic order compared to a verbal order.Data were collected from January 1, 2012 to May 31, 2016. A quality improvement team of perioperative physicians, nurses, and pharmacists implemented a series of interventions including new electronic medical record order sets, personal provider antibiotic dose badges, and utilization of pharmacists to prepare antibiotics to increase compliance with the recommended dose. Process compliance was measured using a statistical process control chart, and dose compliance was measured through electronic analysis of the electronic medical record. Secondary aim data were displayed as percentage of dose compliance. An unpaired t-test was used to determine differences between groups.Between January 1, 2012 and May 31, 2016, cefazolin was administered to 9086 patients. The mean compliance of cefazolin at 30 mgkg(-1) from May 2013 to March 2014 was 40%, which prompted initiation of this project. From April 2014 to May 2016, a series of interventions were deployed. The mean compliance from September 2015 to May 2016 was 93% with significantly reduced variation and no special cause variation, indicating that the process was in control at the target primary aim. There were 649 cefazolin administrations given verbally and 1929 given with an electronic order between October 1, 2014 and May 31, 2016. During this time period, the rate of compliance of administering cefazolin at 30 mgkg(-1) was significantly higher when given after an electronic order than when given verbally, 94% vs 76%.This comprehensive quality improvement project improved practitioner compliance with evidence-based preoperative antimicrobial dosing recommendations to reduce the risk of surgical site infections.

View details for DOI 10.1111/pan.13137

View details for PubMedID 28321988

Anchoring Bias as a Limiting Factor in High-Value Care: A Case of Fever of Unknown Origin in a Hospitalized Child. Hospital pediatrics Festa, N., Park, K. T., Schwenk, H. 2016; 6 (11): 699-701

View details for PubMedID 27789539

Fever and Renal Failure in a Child With DiGeorge Syndrome and Tetralogy of Fallot. Journal of the Pediatric Infectious Diseases Society Itoh, M., Kann, D. C., Schwenk, H. T., Gans, H. A. 2015; 4 (4): 373-375

View details for DOI 10.1093/jpids/piv029

View details for PubMedID 26407263

Bordetella petrii Sinusitis in an Immunocompromised Adolescent. Pediatric infectious disease journal Nagata, J. M., Charville, G. W., Klotz, J. M., Wickremasinghe, W. R., Kann, D. C., Schwenk, H. T., Longhurst, C. A. 2015; 34 (4): 458-?

View details for DOI 10.1097/INF.0000000000000564

View details for PubMedID 25760569

Coping with college and inflammatory bowel disease: implications for clinical guidance and support. Inflammatory bowel diseases Schwenk, H. T., Lightdale, J. R., Arnold, J. H., Goldmann, D. A., Weitzman, E. R. 2014; 20 (9): 1618-1627

Abstract

Studies have shown that young adults with chronic diseases, including inflammatory bowel disease (IBD), experience greater difficulty during the transition to college, reaching lower levels of educational attainment and reporting greater levels of perceived stress than their otherwise-healthy peers. We performed a qualitative study to better understand how underlying illness shapes the college experience for patients with IBD and how the college experience, in turn, impacts disease management.Fifteen college students with IBD were recruited from the Boston Children's Hospital Center for IBD. We conducted an approximately 1 hour semistructured qualitative interview with each participant, and the interviews were thematically analyzed after an iterative and inductive process.Four primary themes were identified: (1) The transition experience of college students with IBD is shaped by their health status, perceived readiness, and preparedness, (2) Elements of the college environment pose specific challenges to young adults with IBD that require adaptive strategies, (3) College students with IBD integrate their underlying illness with their individual and social identity, and (4) College students navigate health management by conceptualizing themselves, their families, and providers as serving particular roles.For young adults with IBD, college is a proving ground for demonstrating self-care and disease management practices. Future initiatives aimed at this population should recognize the evolving roles of patients, parents, and providers in disease management. Increased attention should also be paid to the promotion of patient's self-management and the unique challenges of the structural and psychosocial college environment.

View details for DOI 10.1097/MIB.0000000000000124

View details for PubMedID 25105948

Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review. Pediatric infectious disease journal Schwenk, H., Ramirez-Avila, L., Sheu, S., Wuthrich, C., Waugh, J., Was, A., DeGirolami, U., Burchett, S., Koralnik, I. J., Ahmed, A. 2014; 33 (4): e99-105

Abstract

Progressive multifocal leukoencephalopathy is a rare, demyelinating disease of the central nervous system caused by JC virus. Fewer than 30 cases have been reported in HIV- and non-infected children. We report the case of a 15-year-old girl with progressive multifocal leukoencephalopathy and AIDS who presented with nystagmus, dysarthria and ataxia. Following combined antiretroviral therapy, she developed immune reconstitution inflammatory syndrome, which proved fatal.

View details for DOI 10.1097/INF.0000000000000237

View details for PubMedID 24632669

Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review. Pediatric infectious disease journal Schwenk, H., Ramirez-Avila, L., Sheu, S., Wuthrich, C., Waugh, J., Was, A., DeGirolami, U., Burchett, S., Koralnik, I. J., Ahmed, A. 2014; 33 (4): e99-e105

View details for DOI 10.1097/INF.0000000000000237

View details for PubMedID 24632669

Vancomycin Use for Pediatric Clostridium difficile Infection Is Increasing and Associated with Specific Patient Characteristics ANTIMICROBIAL AGENTS AND CHEMOTHERAPY Schwenk, H. T., Graham, D. A., Sharma, T. S., Sandora, T. J. 2013; 57 (9): 4307-4313